Global life science companies reused only 9% of their commercial content in 2022. Boosting this rate by even a few percentage points would create savings for strategic reinvestment.

Learn more about Veeva Pulse data and how it can help you benchmark and improve your processes.

Commercial Summit Europe - Powerful Community, Fresh Ideas

Madrid | 5–6 November, 2025

Register Now